Cancer photodiagnostic agent - Photocure

Drug Profile

Cancer photodiagnostic agent - Photocure

Alternative Names: Lumacan

Latest Information Update: 16 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PhotoCure
  • Developer Photocure
  • Class Diagnostic agents
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Suspended Colorectal cancer

Most Recent Events

  • 01 Apr 2015 Salix Pharmaceuticals has been acquired by Valeant Pharmaceuticals International
  • 01 Dec 2012 Phase-I/II clinical trials in Colorectal cancer in Germany (Rectal; enema)
  • 29 Oct 2010 Phase I/II development is ongoing in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top